Products & Services

Our capabilities place AAHI at the intersection of emerging sciences, medicine, and the business of biomedicine, enabling us to provide technologies, services, and insights that advance the state-of-the art for the entire biomedical community.

AAHI provides custom vaccine and immunotherapy solutions to enhance vaccines with next generation features and functionality, translating into unique products capable of addressing pressing global health needs.

AAHI is uniquely positioned to support the development of products on our immune-enhancing platforms from bench to clinic. Our partnerships with large pharmaceuticals will enable us to bring our products to market, providing accessibility around the world.

Learn more about AAHI’s adjuvant formulations by visiting the Adjuvant Catalogue

Learn more about AAHI’s RNA Vaccine delivery vehicle

AAHI Pipeline

AAHI’s adjuvant technology has been clinically tested in nearly 10,000 human volunteers with an outstanding safety profile.

Adjuvant
Preclinical
GMP/Tox
Phase 1
Phase 2
Phase 3
Squalene Emulsion
SE
 
 
 
 
TLR 4 Agonists
GLA-SE
 
 
 
 
GLA-AF/Alum
 
 
 
 
SLA-SE
 
 
 
 
TLR/ 7/8 Agonists
3M-052-AF/Alum
 
 
 
 
3M-052-SE
 
 
 
 
TLR 4 Agonists + Saponin
GLA-LSQ
 
 
 
 
SLA-LSQ
 
 
 
 
Dual Agonist
GLA-3M-052-LS
 
 
 
 
RNA Delivery Vehicle
Preclinical
GMP/Tox
Phase 1
Phase 2
Phase 3
Nanostructured Lipid Carrier
NLC
 
 
 
 

Services

IDRI offers world-class expertise in the design, formulation, and manufacture of vaccines, adjuvants, immunotherapies, and their components.